- Home
- OMH vs ADXN Comparison
OMH vs ADXN Comparison
Compare OMH & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- ADXN
- Stock Information
- Founded
- OMH 2015
- ADXN 2002
- Country
- OMH Singapore
- ADXN Switzerland
- Employees
- OMH N/A
- ADXN N/A
- Industry
- OMH Real Estate
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- OMH Finance
- ADXN Health Care
- Exchange
- OMH Nasdaq
- ADXN Nasdaq
- Market Cap
- OMH 9.1M
- ADXN 8.0M
- IPO Year
- OMH 2023
- ADXN N/A
- Fundamental
- Price
- OMH $0.51
- ADXN $8.37
- Analyst Decision
- OMH Strong Buy
- ADXN Strong Buy
- Analyst Count
- OMH 1
- ADXN 1
- Target Price
- OMH $1.50
- ADXN $30.00
- AVG Volume (30 Days)
- OMH 254.3K
- ADXN 17.0K
- Earning Date
- OMH 01-10-2025
- ADXN 11-22-2024
- Dividend Yield
- OMH N/A
- ADXN N/A
- EPS Growth
- OMH N/A
- ADXN N/A
- EPS
- OMH N/A
- ADXN 0.06
- Revenue
- OMH $5,390,607.00
- ADXN $701,260.00
- Revenue This Year
- OMH $101.90
- ADXN N/A
- Revenue Next Year
- OMH $38.34
- ADXN N/A
- P/E Ratio
- OMH N/A
- ADXN $1.11
- Revenue Growth
- OMH 25.77
- ADXN N/A
- 52 Week Low
- OMH $0.32
- ADXN $6.00
- 52 Week High
- OMH $6.00
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- OMH 69.54
- ADXN 53.02
- Support Level
- OMH $0.37
- ADXN $7.00
- Resistance Level
- OMH $0.43
- ADXN $8.66
- Average True Range (ATR)
- OMH 0.03
- ADXN 0.57
- MACD
- OMH 0.01
- ADXN 0.08
- Stochastic Oscillator
- OMH 100.00
- ADXN 82.63
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.